跳至主要内容
临床试验/2024-514307-34-01
2024-514307-34-01招募中2 期

A randomized, double-blind parallel group study to investigate propofol injection pain compared with placebo in healthy adult male and female participants. (PropPain)

Oslo University Hospital HF1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月1日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
• Proportion of participants with VAS≥30 mm (0-100mm)

研究概览

简要总结

• Determine proportion of participants experiencing significant pain by intravenous injection of propofol or placebo

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • The participant is overtly healthy as determined by medical evaluation including medical history and physical examination
  • Participant is ≥ 18 and < 50 years of age
  • Highly sensitive urine pregnancy test is negative for WOCBP
  • The participant must give a signed informed consent as described in Appendix 1 which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol

排除标准

  • Known allergy or intolerance to the study intervention propofol
  • Known neurological illnesses (eg epilepsy)
  • Known allergy or intolerance to eggs, soya or peanuts
  • BMI is <16 and ≥30
  • Use of analgesics or alcohol the last 24 h before study intervention
  • The participant is breastfeeding
  • The participant uses other medication(s) incompatible with the simultaneous use of propofol (e.g. benzodiazepines, hypnotics, narcotics, excessive alcohol use)
  • Participation in other clinical studies within the last two months before study intervention
  • Not meeting the rules of fasting according to the protocol
  • Any condition that in the view of the investigators would suggest that the patient is unable to comply with the study protocol and procedures.

结局指标

主要结局

• Proportion of participants with VAS≥30 mm (0-100mm)

• Proportion of participants with VAS≥30 mm (0-100mm)

次要结局

  • • • Max electronic Visual Analog Scale (VAS) pain (0-100 mm)
  • • Max Numeric Rating Scale (NRS) pain (0-10)
  • • Time (seconds) to max electronic Visual Analog Scale (VAS) pain
  • • Area under the curve (AUC) 0-1 min, 1-2 min, 2-3 min
  • • Area under the curve VAS≥30 (AUCVAS≥30) 0-1 min, 1-2 min, 2-3 min
  • • Curve shape of electronic Visual Analog Scale (VAS) pain (0-100 mm) by description of the curve (number of peaks)
  • • Richmond Agitation-Sedation Scale (RASS)

研究者

发起方
Oslo University Hospital HF
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Marianne Myhre

Scientific

Oslo University Hospital HF

研究点 (1)

Loading locations...

相似试验